Takada et al. [18] demonstrated that tumors with higher PD-L1 levels tend to have higher glycolytic metabolism, and SUVmax is a predictor of PD-L1 protein expression in NSCLC patients. Here, CD274 is linked to non-small cell lung carcinoma.